Retatrutide, a versatile drug, showed significant weight loss, musculoskeletal issues, and sleep disorders in clinical trials. The drug caused considerable decrease in body mass and reduced A1C levels in people with excess weight and type 2 diabetes. The results were reported in FirstWord, showing the drug's potential in addressing diverse health concerns.
More Top Stories
Wage Boosts Approved for Five Canadian Provinces
Minimum wage increases will take effect in five provinces on October 1, 2026. Workers in Toronto will receive...
The 2026 flu season kicks off early
The 2026 flu season has begun early, with a rise in respiratory infections. Free flu shots are available for c...
South Africa's challenge falls short against Australia in ODI
Australia scored 322 runs in their match against South Africa. Marsh and Carey contributed significantly contr...
The FA Trophy first round draw is complete: 32 matches for October 2026
The FA Trophy first round draw was announced on Monday. Thirty two matches are set for October 24, 2026. Worki...
Recent Lotto 6/49 Draws Yield Winners
Recent Lotto 6/49 draws resulted in huge jackpots awarded. In Canada and Quebec, the jackpot hit 5 million dol...
Smalling Agrees to Join FC Porto on One-Year Contract
Chris Smalling, a former Manchester United and England center back, is in negotiations to join FC Porto on a o...
Daily Digest · Daily Digest · News Roundup · News Roundup · Weekly Review · Daily Digest · Weekly Review · Latest Update · Community Report · Weekly Review · Latest Update · Weekly Review · Weekly Review · Daily Digest · Weekly Review · Weekly Review · Latest Update · Weekly Review · Latest Update · Community Report · Weekly Review · Latest Update · Daily Digest · Weekly Review · Community Report · News Roundup · Latest Update · Latest Update · News Roundup · Weekly Review · Latest Update · Local Briefing · Latest Update · Community Report · Latest Update · News Roundup · Community Report · Latest Update · Daily Digest · Local Briefing